AI-assisted, human-published
11/20/2025 /Funding Events
Aspen Neuroscience Secures $115 Million in Series C Funding for Parkinson's Disease Program
Aspen Neuroscience, Inc., secures $115 million in a Series C financing round led by prominent investors to advance its lead program, ANPD001, aimed at treating moderate to advanced Parkinson's disease.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com